Currently, a phase II trial (NCT05350969) is ongoing to evaluate the potential of CDR132L to prevent or reverse cardiac remodeling in patients with HFrEF following MI
Monitoring Progress When Using Daily Glutathione Biomarkers and Lab Guidance Laboratory markers such as liver enzymes, oxidative stress indicators, and glutathione metabolites offer valuable insight
Possible Side Effects While generally well-tolerated, some individuals may experience mild side effects such as: Pain, redness, or swelling at the injection site Mild diarrhea or stomach upset Allergic reactions like rash, itching, or dizziness in rare cases Headache or flushing due to niacinamide content Any persistent or severe symptoms should be reported to a healthcare professional promptly
doi: 10.1038/nutd.2016.44
Side Effects: Occasional headaches, nausea, and flushing
That said, side effects can occur: Common side effects (mild and transient) Injection site reactions: Redness, mild swelling, or tenderness at injection sites
